Trials
Search / Trial NCT05636657

Comparative Study of Intestinal Color Ultrasound and Capsule Endoscopy in Monitoring Crohn's Disease

Launched by NANFANG HOSPITAL, SOUTHERN MEDICAL UNIVERSITY · Dec 1, 2022

Trial Information

Current as of February 05, 2025

Not yet recruiting

Keywords

Intestinal Color Ultrasound Capsule Endoscopy Sus Cd Cecdai

ClinConnect Summary

The disease activity index under intestinal color ultrasound was evaluated by SUS-CD, and the disease activity index under capsule endoscopy was evaluated by CECDAI. Active lesions under intestinal color ultrasound were defined as SUS-CD ≥ 1, and active lesions under capsule endoscopy were defined as CECDAI ≥ 3.9. All subjects underwent intestinal color ultrasound and capsule endoscopy at baseline and 3 months after treatment. To compare the correlation between SUS-CD and CECDAI before and after treatment, and to compare the role of intestinal color ultrasound and capsule endoscopy in monit...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1.Patients diagnosed with Crohn's disease according to the 2019 European Guidelines for Crohn's disease;
  • 2.At the time of inclusion, there were active lesions under color ultrasound or capsule endoscopy;
  • 3.Voluntarily sign an informed consent form.
  • Exclusion Criteria:
  • 1.Patients with contraindications for capsule endoscopy;
  • 2.In the judgment of the investigator, it is not suitable to participate in this study.

Trial Officials

Xinmei Zhao, doctor

Study Chair

Nanfang Hospital, Southern Medical University

About Nanfang Hospital, Southern Medical University

Nanfang Hospital, affiliated with Southern Medical University, is a leading medical institution in China renowned for its comprehensive clinical services and commitment to advancing healthcare through research and education. As a clinical trial sponsor, Nanfang Hospital leverages its state-of-the-art facilities and a multidisciplinary team of expert researchers to conduct innovative studies aimed at improving patient outcomes and contributing to the global medical community. The hospital's focus on ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and scientific rigor.

Locations

Guangzhou, Guangdong, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials